Human respiratory syncytial virus medical therapy: Difference between revisions
Esther Lee (talk | contribs) Created page with "__NOTOC__ {{Human respiratory syncytial virus}} {{CMG}} ==Overivew== ==Medical Therapy== Ribavirin, a broad-spectrum antiviral agent, was once employed as adjunctive the..." |
No edit summary |
||
Line 2: | Line 2: | ||
{{Human respiratory syncytial virus}} | {{Human respiratory syncytial virus}} | ||
{{CMG}} | {{CMG}} | ||
==Medical Therapy== | ==Medical Therapy== | ||
Line 16: | Line 14: | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Mononegavirales]] | [[Category:Mononegavirales]] | ||
[[Category: | [[Category:Needs overview]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 18:19, 10 December 2012
Human respiratory syncytial virus Microchapters |
Differentiating Human Respiratory Syncytial Virus from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Human respiratory syncytial virus medical therapy On the Web |
American Roentgen Ray Society Images of Human respiratory syncytial virus medical therapy |
Human respiratory syncytial virus medical therapy in the news |
Directions to Hospitals Treating Human respiratory syncytial virus |
Risk calculators and risk factors for Human respiratory syncytial virus medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Ribavirin, a broad-spectrum antiviral agent, was once employed as adjunctive therapy for the sickest patients; however, its efficacy has been called into question by multiple studies, and most institutions no longer use it.
Treatment is otherwise supportive care only with fluids and oxygen until the illness runs its course.